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ABSTRACT 
 
Background 
 
Tobacco secondhand smoke (SHS) has long being known for all its negative health 
effects. This work aimed to determine the SHS exposure rate in the pregnant population 
of Soweto and to determine their demographic characteristics. We also aimed to 
explore Soweto pregnant women’s knowledge, attitude and practice towards SHS 
exposure. 
 
Methods 
 
This was a prospective, cross sectional study undertaken at Chris Hani Baragwanath 
Academic Hospital, a tertiary hospital situated in Soweto. Soweto serves in excess of 
two million people, with more than 23 000 delivers annually in the hospital. This study 
used a questionnaire to survey a sample of pregnant women who were post caesarean 
section. 
 
Results 
 
A total of 100 women were interviewed.  Twenty one percent reported to be exposed to 
SHS at home and 18% of the employed participants reported to be exposed at work.  
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Forty three percent of the participants lived with a regular smoker and 73% had banned 
smoking in their house. However, even though the bans had been put in place, smoking 
still occurred in some of their homes.  The demographic characteristics of the SHS-
exposed participants compared to the non-exposed participants were similar. There was 
a statistically significant difference in the number of regular smokers that the participant 
lived with, with SHS-exposed participants being more likely to live with a regular smoker 
than with no regular smokers in the house.  Ninety two percent of the participants 
reported they did not think it was appropriate that women smoke, even though some of 
them had previously been smokers themselves.  Ninety one percent of participants 
were aware that SHS could have a negative effect on their babies while pregnant, and 
knew about health risks with SHS.      
 
Conclusion 
 
This study showed that in spite of strict anti-tobacco laws, a high percentage of 
pregnant women reported to be exposed to SHS at home and at work. Most were aware 
of the health risks of SHS, and tried to ban smoking in their homes. 
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1. INTRODUCTION 
 
The effects of secondhand smoke (SHS) exposure on a pregnant woman’s health as 
well as fetal outcomes are well documented. High-income as well as many lower-
income countries have documented their SHS exposure rates, and health effects from 
smoking and SHS are included in antenatal care programmes. South African pregnant 
women’s exposure rate to SHS is unknown, and data are urgently needed, taking into 
account the serious adverse effects of SHS.     
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2. SMOKING 
 
Tobacco is a plant that has been growing as a crop since 6000 BC in the Andes [1] and 
was originally used in a medicinal capacity [2] being later introduced into Europe by 
Christopher Columbus [1]. It has been speculated that tobacco initially was used for 
chewing and later as ‘snuffing’ tobacco (which is to take in powdered tobacco through 
the nose). Snuffing tubes are among the earliest tobacco artefacts discovered in 
America [1,2]. 
 
Smoking can be defined as the action in which a substance, usually tobacco leaves, is 
burned and the resulting smoke is inhaled and exhaled [3]. Mainstream smoke is the 
smoke exhaled by the smoker whereas side-stream smoke is the smoke that emits from 
the burning cigarette tip [4,5]. 
 
Inhaled smoke contains more than 4000 chemicals [6], of which 69 known carcinogens 
are in mainstream smoke as well as side-stream smoke [3,6]. Tobacco smoke is a 
complex, dynamic and reactive mixture and is probably the most significant source of 
toxic chemical exposure and chemically mediated diseases in humans [7].   
 
The perpetual cycle of tobacco use in families was confirmed by Green et al. from 
Scotland who showed with regard to young smokers that two aspects played a role 
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namely: social class and parental smoking behaviour. The most likely candidates 
amongst young people that smoke are those whose parents smoked as well as those 
from lower social class households [8]. Maternal tobacco use not only is a risk for likely 
exposure of infants and children to SHS but also it provides a role model for children’s 
tobacco use [8].    
 
A four year prospective study by DiFranza et al. reported that once exposure to nicotine 
had occurred, relative to the theory that the process of dependence is initiated by the 
first dose of nicotine, there were few risk factors for smoking which consistently 
contributed to individual differences in susceptibility to developing dependence or loss 
of autonomy. Among 217 youths who had inhaled from a cigarette, those feeling either 
relaxed their first time and those with depressed mood were both predictors for loss of 
autonomy from cigarettes. Tobacco dependence was predicted by feeling relaxed, 
familiarity with Joe Camel (a cartoon character used in a controversial advertising 
campaign by the brand Camel targeting adolescents), novelty seeking, and depressed 
mood [9]. 
 
Pierce et al. performed a longitudinal study on 4500 adolescents looking at the 
predictive validity of smoking susceptibility. From the sample group, over a four year 
period, 40% had experimented with smoking and 8% had established a smoking habit. 
Baseline susceptibility to smoking, defined as the absence of a firm decision not to 
smoke, was a stronger independent predictor of experimentation than the presence of 
smokers among either family or the best friend network. However, susceptibility to 
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becoming an established smoker was increased by the presence of smokers among 
either family or best friend network [10]. 
 
2.1 Smoking, secondhand smoke, and the burden of disease   
 
One of the largest yet theoretically preventable public health threats worldwide is the 
tobacco smoking epidemic [11]. Tobacco smoking causes an estimated six million 
deaths per annum, of which 600 000 are the result of non-smokers being exposed to 
SHS [11], also known as environmental tobacco smoke or passive smoking. It has been 
postulated that if the tobacco use continues following current trends, the total annual 
burden could rise to more than eight million deaths by 2030 [11]. Not only is smoking 
the leading preventable cause of mortality in the United States of America (USA) [3], but 
according to the Centre for Disease Control, it is also responsible for a threefold 
increase in early mortality rate for smokers [12]. 
 
Groenewald et al. found that smoking creates a large burden of preventable diseases in 
South Africa [13]. They reported that smoking accounts for 8-9% of deaths and 3.7-
4.3% of disability-adjusted life years and is also the third highest risk factor for mortality 
[13]. Regarding gender distribution they found that three times as many males as 
females died from smoking and that the largest attributable factor to the development of 
lung cancer is smoking. However, cardiovascular diseases accounted for the largest 
proportion of deaths secondary to smoking [13]. Cigarette smoking affects nearly every 
15 
organ of the body, resulting in a multitude of diseases and is known to decrease general 
health among smokers [14, 15].  SHS causes both disease and death in non-smokers, 
and is a substantial health risk [16]. In 2004, an estimated 53 000 people in Africa died 
from SHS exposure. Globally, in 2004, 10.9 million disability-adjusted life years, 1.7 
million of which were in Africa, were attributed to SHS [17]. In a 2008 study of South 
African adolescents, 26% were exposed to SHS at home and 34% outside the home 
[18].   
 
2.2 Smoking and women 
 
Tobacco research conducted in 2008 by Steyn et al. revealed that 11% of South African 
women were regular smokers [19]. Regarding cancer, in the USA more woman have 
died from lung cancer as a result of smoking than from breast cancer [12] since the mid-
1980s [20]. Between 1960 and 1990, deaths from lung cancer among women increased 
by more than 400% [20].  Smoking impacts negatively on women’s reproductive health 
and is associated with reduced fertility and early menopause [21]. 
 
2.3 Smoking in pregnancy and pregnancy outcomes 
 
Cigarette smoking during pregnancy is a public health issue that has a significant effect 
not only on maternal health but also on fetal health [22,23]. Smoking during pregnancy 
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subjects women and their offspring to significant risks. These include preterm birth, low-
birthweight infants, stillbirth, and infant mortality [21]. Many women stop smoking when 
they become aware that they are pregnant, but some do not. Homish et al. studied 
smoking cessation in the first trimester of pregnancy and what impact the pre-
conception social environment has on smoking cessation [23]. They found that women 
whose partners, but not other household members, were smokers were more likely to 
smoke during the first trimester [23]. Additionally, women who had a greater proportion 
of friends [not relatives] who were smokers, and more frequent exposure to SHS, were 
more likely to smoke [23].   
   
For more than 50 years the association between maternal smoking and preterm birth 
has been known [24]. In a review of five meta-analyses, Castles et al. looked at the 
effects of smoking on five pregnancy complications: placenta praevia, abruptio 
placentae, ectopic pregnancy, preterm premature rupture of the membranes and pre-
eclampsia [25]. The analysis showed that smoking during pregnancy is a significant 
preventable risk factor for ectopic pregnancy, placental abruption, placenta praevia, and 
prelabour preterm rupture of membranes, while being associated with a reduction in the 
risk of pre-eclampsia [25].   
 
In a review written in 2005 on the adverse effects of maternal smoking on the human 
placenta, Zdravkovic et al. found the following. Firstly, maternal smoking impairs 
placental development as it is shown to change the balance between cytotrophoblast 
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proliferation and differentiation. This is mediated by smoking-induced changes in 
molecular pathways associated with oxygen tension, as oxygen is involved in controlling 
the balance between cytotrophoblast proliferation and differentiation. Hypoxia induces 
dysregulation of cytotrophoblast expression of von Hippel-Lindau tumor suppressor 
protein, hypoxia-inducible transcription factors and vascular endothelial growth factor-A 
[VEGF]. These effects are also found in women exposed to SHS during pregnancy.  
Secondly, it is hypothesized that placental development is likely affected directly and 
indirectly as a result of decreased blood flow associated with chronic smoking which 
causes a pathologically hypoxic environment. [26].  
 
Other deleterious effects have been described. Klesges et al. showed increased 
calcifications in term placentas of women who smoke, which is thought to be a sign of 
hypoxic injury [27]. This occurs in order to compensate for the reduced blood flow in the 
placentas of women who smoke [28]. Additionally, there is evidence that maternal 
smoking alters other aspects of placental function, including progesterone production 
[29], estrogen metabolism [30], amino acid transport [31], and the activity of drug-
metabolizing enzymes [32] which exacerbates the negative effects of birth weight [33].  
The apparent protective effect of smoking on pre-eclampsia is probably counter-
balanced by the known harmful effects [25].  Pre-eclampsia is associated with altered 
maternal vascular function and impaired fetal growth [34].  Maternal smoking enhances 
expression of VEGF ligands [35], which may explain why mothers who smoke have a 
lower risk of preeclampsia [26]. Besides the stimulation of proangiogenic factors, such 
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as VEGF, there may be a reduction in antiangiogenic factors, such as soluble VEGF 
receptor Flt-1[36]. With regard to maternal vascular function related to smoking’s 
protective effect, two mechanisms have been proposed. Firstly is the exposure to 
thiocyanate in cigarette smoke, which has a hypotensive effect [37], and secondly an 
inhibition of thromboxane A2 production and/or increase in levels of prostacyclin [38]. 
 
Maternal smoking and its effect on fetal growth cannot be directly assessed therefore 
birth weight is used even though birth weight is not just a reflection of fetal growth but 
also a reflection of gestational age and genetic potential. Other studies use intrauterine 
growth restriction as a reflection of fetal growth. The 2004 Surgeon General’s report 
from the USA concluded that “evidence is sufficient to infer a causal relationship 
between maternal active smoking and fetal growth restriction and low birth weight” [39]. 
And the 2006 Surgeon General’s report concluded further that “evidence is sufficient to 
infer a causal relationship between exposure to secondhand smoke and a small 
reduction in birth weight” [40]. From a South African perspective, in the Birth to Ten 
study by Steyn et al. on a cohort of 1593 woman living in Soweto and Johannesburg, it 
was concluded that infants of maternal smokers had significantly lower birth weights 
(137 g) than non-smokers or snuff users. Second hand smoking did not affect 
birthweight significantly [41].  
 
Smoking in pregnancy causes early morphological changes of the placenta [42]. This 
results in a decreased intervillous space volume and surface area of fetal capillaries, 
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causing less oxygen diffusion across the placenta [43]. The fetus therefore is exposed 
to chronic hypoxic stress [43].  These factors contribute to a lower birth weight and 
length, and a smaller head circumference [44].  According to data from a Canadian 
cohort study by Anderson et al. it is estimated that smoking during pregnancy reduces 
birth weight by 10–15 grams per cigarette smoked daily [45].  More recently, Wang et al. 
concluded that the effects of smoking during pregnancy on birth weight and gestational 
age may even be stronger depending on individual susceptibility [33].  Low birth weight 
has significant long term effects on future health, including increase risks of coronary 
heart disease, stroke, hypertension, type 2 diabetes mellitus, insulin resistance, and 
high low-density lipoprotein levels. Of significance is that in developing countries, these 
associations seem to be stronger [46]. 
 
Bouyer et al. reported a strong association between tobacco use and ectopic pregnancy 
based on several studies, and this association was confirmed by their own study 
demonstrating a dose-effect relation. They found that smoking cessation reduced the 
risk of ectopic pregnancy to an intermediate level between that of current smokers and 
that of women who have never smoked. Among previous smokers, the time since 
smoking cessation was not associated with ectopic pregnancy risk [47].  
 
Ananth et al. found that cigarette smoking was associated with a twofold increase in the 
risk of placental abruption [48].  The relative risk of placental abruption related to 
smoking is between 1.4 and 2.5 [48, 49]. Smoking has a 2.5 fold increased risk for 
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severe abruption resulting in fetal death [49]. It has been reported that the risk of 
abruption increases with the number of cigarettes smoked per day [48] up to a 
maximum of 10 cigarettes per day after which the risk remains constant [50]. The 
mechanisms by which maternal smoking increases the risk for abruption remain 
unclear. Studies have suggested that the mechanism of abruption in smokers is initiated 
by decidual necrosis at the margin of the placenta [51, 52], or a decreased placental 
blood flow [53], possibly mediated through changes in production of vasoactive 
substances such as prostacyclin and nitric oxide [54], or endothelial cell damage [55]. In 
a case-control study by Kaminsky et al. histological evaluations were carried out on 189 
cases of placental abruption [54].  They concluded that placental abruption due to 
cigarette smoking may be associated with chorionic villous hemorrhage and intervillous 
thrombosis [54]. 
In a systematic review published in 2011 by Hackshaw et al. based on 173 687 cases 
and 11.7 million controls from 127 articles from 1959-2010, the following birth defects 
are associated with maternal smoking: cardiovascular/heart defects [OR 1.09, 95% 
confidence interval (CI) 1.02–1.17],  musculoskeletal defects [OR 1.16, 95% CI 1.05–
1.27], limb reduction defects [OR 1.26, 95% CI 1.15–1.39], missing/extra digits [OR 
1.18, 95% CI 0.99–1.41], clubfoot [OR 1.28, 95% CI 1.10–1.47], craniosynostosis [OR 
1.33, 95% CI 1.03–1.73], facial defects [OR 1.19, 95% CI 1.06–1.35], eye defects [OR 
1.25, 95% CI 1.11-1.40], orofacial clefts [OR 1.28, 95% CI 1.20–1.36], gastrointestinal 
defects [OR 1.27, 95% CI 1.18–1.36], gastroschisis [OR 1.50, 95% CI 1.28–1.76], anal 
atresia [OR 1.20, 95% CI 1.06–1.36], hernias  [OR 1.40, 95% CI 1.23–1.59] and 
undescended testes [OR 1.13, 95% CI 1.02–1.25]. They concluded that the above 
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should be part of public health educational materials to encourage more women to quit 
before or during pregnancy [56]. 
 
2.4 Smoking prevalence and socio-demographics 
 
According to the World Health Organisation, worldwide, there are an estimated 1.1 
billion people who smoke and nearly 80% of these smokers live in low-and middle-
income countries, where the burden of tobacco-related illness and death is the most 
[11].  Arnold et al. found that although the overall smoking rates for the American 
population had decreased since 1992, there has been an increase in smoking among 
women, teenagers, and poverty stricken adults [22]. Smoking rates tend to also be 
associated with level of education. A three times higher rate of smoking is reported in 
women with less than a high school education when compared to with college 
graduates [14].The highest burden of smoking in females is among low-income women 
[23].  Arnold et al. also assessed reading level, tobacco knowledge, attitudes, and 
practices of tobacco use among pregnant adults and adolescent women. They found 
that the variation in women’s knowledge about the effects of smoking and concerns 
about the health effect of smoking on their babies was related to their reading level. It 
was found that the higher the reading levels, the more knowledge and greater concern 
the participant had. Smoking practices and prevalence however were not affected by 
reading level. Another significant determinant reported was race, with more white 
women smoking during pregnancy than African Americans (34% vs 8%) [22]. 
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Chomba et al. found in their study of women in Zambia and the Democratic Republic of 
Congo (DRC) that literate pregnant woman were significantly less likely to live with other 
tobacco users, live in a home where tobacco smoking was permitted and to have their 
young children exposed to tobacco smoke indoors, compared to other woman [57]. In 
developing countries, the prevalence of smoking among women has been low due to 
strong cultural constraints against women's smoking [58]. About 50% of men in 
developing countries smoke cigarettes, compared to only 9% of women [15].  Yach et 
al. reported that smoking related deaths in South Africa need to be explored with an 
understanding of the underlying demographic and epidemiological changes in the 
country, which are strongly related to race [59]. The overall smoking rate in South 
Africa, in 1990, in people over 16 years of age was 31%. The lowest smoking rates 
were those who had a university education. Smoking rates among African and coloured 
men were particularly high with a significant increase in smoking in these groups from 
1976-1990 [59]. The proportion of women who smoke remained low and remained 
unchanged among Africans from 1976-1990 [59].  
 
Van Walbeek found that in South Africa, between 1993 and 2002, average cigarette 
consumption decreased by 26%, attributed to a sharp increase in cigarette retail costs. 
Smoking prevalence decreased from 32% to 27% of the adult population [60]. He also 
stated that smoking prevalence had decreased for the majority of the named 
demographic and socio-economic groups. The most significant decreases were in 
males, blacks, young adults and low income households. Coloureds, whites, females 
and high income households did not show a significant decrease in smoking 
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prevalence.  Tobacco use research, conducted in 1998 in South Africa by Steyn et al, 
showed that among women the rates of cigarette smoking varied with race. Coloured 
women had a higher rate of smoking [39%] than African women [5.4%] [19].   
 
Regarding smokeless tobacco, worldwide high rates of use have been reported in 
young people [61], and more so among girls [62].
 
In South East Asia, smoking among 
women is reportedly rare, but the use of smokeless tobacco is common [63]. Gupta 
conducted a study in India of 59 527 lower middle class and lower class women aged 
35 years and older, and reported that 57.5% were current users of tobacco, 99.6% of 
which was smokeless [64]. In South Africa, African woman use smokeless tobacco 
more frequently than woman of other races [19].  The effects of smokeless tobacco on 
fetal health are similar to those of cigarette smoking, and appear to be dose dependent 
[10, 65]. Data from India on smokeless tobacco use in pregnant woman shows a 
decrease in birth weight. In 1978, Krishna reported that of 1388 singleton births in India, 
tobacco chewers had babies with a birth weight deficit of 100-200 g, independent of 
maternal weight, socioeconomic status, and gestational age [66]. More recent work by 
Mehta et al showed that, of 178 deliveries, there was a 65% incidence of low birth 
weight babies in smokeless tobacco users, twice as high as that of non-users [67].  
 
2.5 South Africa’s health and smoking laws  
 
South Africa has a combination of public health issues.  These are a high incidence of 
heart disease and cancer (non-communicable diseases) as seen in developed 
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countries, mainly among white and Asian populations, and then disease patterns 
associated with poverty, such as preventable infectious and nutritional diseases, more 
prevalent among the African and coloured populations [59].  The tobacco companies 
have rapidly used the opportunity of the urbanising population and targeted marketing 
efforts to the latter population groups [59], which now face an additional burden of non-
communicable diseases. 
 
Before 1994, a third of all South Africans smoked, excise taxes were low, and there 
were few tobacco control measures [68].  Van Walbeek reported that increased tobacco 
tax is a powerful policy tool in reducing cigarette consumption [60]. Between 1970 and 
1990, tax rates fell 82%, leading to a 31 percent decrease in retail cigarette prices and a 
139 percent increase in cigarette consumption. Then, between 1994 and 1999 excise 
taxes rose 149 percent, and cigarette prices went up 81 percent, and tobacco 
consumption went down 21 percent [68]. 
 
The South African government implemented the Tobacco Products Control Act of 1993, 
which regulated smoking in public areas, including workplaces, restaurants, bars and 
public transport. It also prohibited tobacco sales to people under the age of 16 and 
regulated tobacco advertising. The amendment to this act in 1999, implemented in 
2000, banned all advertising and promotion of tobacco products, including sponsorship 
as well as distribution of free tobacco products. Yet, despite the South African 
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government’s firm and effective legislative action to discourage tobacco use since 1994, 
smoking remains a major public health priority [13, 69].   
 
Heloma et al. investigated the impact of national smoke-free workplace legislation on 
employee exposure to SHS at work, and on employee smoking habits in firms in 
Finland. They found that exposure to SHS declined considerably one year after the 
legislation was implemented. Tobacco consumption among smokers diminished, 
especially amongst less educated employees who showed a proportionally large 
decrease in smoking. The decrease was especially marked among industrial workers 
[70]. 
 
2.6 SHS and disease 
 
It is only through smokers that the non-smoking population is exposed to SHS and its 
effects.  SHS exposure, a form of involuntary smoking, represents a potentially large 
public health problem worldwide as evidenced by the severe effects of smoking.   
  
According to the American Cancer Society, SHS is a mixture of two forms of smoke that 
come from burning tobacco, namely mainstream smoke and side-stream smoke. Side-
stream smoke is more carcinogenic than mainstream smoke, and inhaled fresh side-
stream cigarette smoke is about four times more toxic per gram total particulate matter 
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than mainstream cigarette smoke [4, 5]. SHS is classified as a known human 
carcinogen by the US Environmental Protection Agency, the US National Toxicology 
Program, and the International Agency for Research on Cancer, a branch of the World 
Health Organisation, as it contains 7000 chemical compounds, of which 69 are known 
carcinogenic chemicals [71]. 
There is substantial evidence that SHS is a major cause of disease in healthy non-
smokers [14]. Evidence has accumulated since the 1980s on the effects of passive 
smoking on lung cancer, coronary heart disease, and chronic obstructive pulmonary 
disease [69]. Diseases such as lung cancer have been linked to SHS exposure with an 
increased risk in SHS of 20-30% increased [72]. The cardiovascular system is also 
significantly affected by SHS exposure, with a 25-30% increased risk of heart disease 
and a 20-30% increased risk of stroke [73].  
 
A Chinese study has suggested that SHS exposure is linked to a dose-dependent 
increased risk of severe dementia [74].  While more research is needed to better 
understand the relationship between SHS, dementia, and mental health [74] there are 
some studies that have investigated a potential link between SHS exposure and mental 
health. A US study on SHS exposure and mental health among children and 
adolescents showed an association between SHS exposure and mental health 
outcomes [75] but it is unknown as to what the biological or psychological mechanism of 
association and further research is recommended [75]. In contrast two studies in the 
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Netherlands found that in non-smoking adults there was no relation between SHS and 
depression [76]. 
 
2.7 SHS, maternal health and pregnancy outcomes 
 
The consequences of SHS on maternal health, pregnancy outcomes and childhood 
health are well documented.  Fertility, conception, survival of the conceptus, and most 
phases of development studied to date, as well as postnatal health are negatively 
impacted by maternal tobacco use or exposure [77]. SHS exposure has adverse effects 
on fertility [14]. Female fertility is affected by altering the balance of hormones that affect 
oocyte production namely growth hormone, cortisol, luteinizing hormone and prolactin 
[40].   
 
In an observational study by Hyland et al. 80 762 women participated in the Women's 
Health Initiative Observational Study and were examined with a cross-sectional analysis 
to determine the relationship between both active smoking and SHS, and pregnancy 
outcomes. Never-smoking women with the highest levels of lifetime exposure to SHS 
had significantly increased estimates of risk for spontaneous abortion, stillbirth and tubal 
ectopic pregnancy [78]. Leonardi-Bee et al. found that SHS exposure increased the risk 
of stillbirth by 23% and was linked to a 13% increased risk of congenital birth defects, 
the detail of the study is provided below. [79]. There is also an increased risk of low birth 
weight and intrauterine growth restriction [14]. The risk of sudden infant death syndrome 
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is more than double if the mother is exposed to SHS in pregnancy [14].   
A meta-analysis by Salmasi et al. included 76 articles with a total of 48 439 women 
exposed to SHS and 90 918 unexposed women. This was the first meta-analysis to 
evaluate the effect of maternal SHS exposure without active maternal smoking on 
perinatal outcomes. The results showed significantly increased risks of SHS for having 
a newborn with low birth weight (<2500 g), longer neonates (by 1.75 cm) and a small 
increased risk of a congenital anomaly (odds ration of 1.17) [80]. No significant 
differences were found between pregnant women who were and were not exposed to 
SHS for small-for-gestation babies, spontaneous abortion, caesarean section or Apgar 
scores at one and five minutes [80]. The meta-analysis could not comment on the 
association between SHS and perinatal mortality, as no studies examined this outcome. 
The authors suggested that if SHS does have an effect on perinatal mortality, it is small. 
[80]. 
 
Two further meta-analyses have been published, by Windham et al. [81], which also 
included maternal active smokers, and by Leonardi-Bee et al. [79], which focused solely 
on the effects of SHS on in utero growth and duration of gestation [80]. Windham et al., 
pooling data from 22 articles, found that, of 992 nonsmoking women exposed to SHS 
for one hour or more per day and paternal smoking, there was an increased risk for low 
birth weight at term [81]. Leonardi – Bee et al. showed that exposure of non-smoking 
pregnant women to SHS reduced mean birth weight by 33 g or more, and increased the 
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risk of birth weight <2500 g by 22%, but had no clear effect on the duration of gestation 
nor the risk of being small for gestational age [79]. 
 
2.8 Effect of SHS on childhood and long-term health 
 
Long term negative effects regarding speech and language skills, intelligence, 
visual/spatial abilities and behaviour have been shown where pregnant woman were 
exposed to SHS [82].  Children of non-smoking mothers not exposed to SHS while 
pregnant performed better with development outcomes mentioned above, than children 
of mothers exposed to SHS during pregnancy [82]. Children of pregnant women 
exposed to SHS appear more likely to suffer from attention deficit hyperactivity disorder 
and conduct disorder [83].  
 
2.9 SHS exposure rates during pregnancy 
 
Various countries have researched SHS exposure rates in their pregnant populations, 
but most of this research has occurred in developed countries.  A variety of methods 
has been reported in the literature to determine the presence and extent of SHS 
exposure, including self-reporting and assays of nicotine or cotinine in non-smokers. 
Cotinine is a major metabolite of nicotine with a longer half-life, and it is considered to 
be a more accurate measure of total SHS exposure than questionnaire methods [81]. 
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Cotinine levels can be measured in serum, hair or saliva. A study by George et al, that 
looked at self-reported nicotine exposure and plasma levels of cotinine in early and late 
pregnancy, found that biochemical methods were superior to self-report when 
determining exposure levels [84]. Similar findings were reported by Sasaki et al. from 
Japan [85]. Ideally, SHS exposure in pregnancy should be studied by both self-report 
and cotinine measurement. 
 
Yet, the systematic review and meta-analysis by Salmasi et al performed a sensitivity 
analysis comparing the results of birth weight according to maternal self-report of SHS 
exposure compared to biochemical analyses [80]. This was done because of concerns 
that self-reporting was unreliable. They found similar decreases in birth weight with 
maternal self-report of SHS exposure and biochemical analyses, justifying the omission 
of formal biochemical verification of SHS exposure. Self-reporting may therefore be 
adequate in determining SHS exposure rates [80].   
 
Bloch et al. carried out a study in nine low- and middle-income countries, using self-
reporting methods to determine percentages of homes where smoking was allowed, 
and SHS exposure rates during pregnancy [58] (Table 2.1). They found that SHS 
exposure in pregnancy was frequent in a variety of countries. Included in Table 2.1 are 
additional statistics from other countries including Canada by Salmasi et al. [80], Japan 
by Sasaki et al. [85] and Torres et al. from the Dominican Republic [86]. 
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Table 2.1. Smoking allowed in homes and SHS exposure rates among pregnant 
women in 13 countries on four continents.  
Continent  Country  % smoking allowed 
in home 
% always/frequently 
exposed to smoking 
indoors 
Latin America Argentina 55.3 30.7 
Latin America Uruguay 54.4 26.5 
Latin America Ecuador 26.9 12.9 
Latin America Brazil 36.2 29.6 
Latin America Guatemala  17.4 13.2 
Africa DRC 17.1 8.3 
Africa Zambia 20.5 13.7 
Asia Orissa, India 55.4 10.8 
Asia Karnataka, India 43.3 19.9 
Asia Pakistan 91.6 49.9 
Asia Japan not reported 63 
North America Dominican republic 76 16 
North America Canada not reported 22-30 
 
 
2.10 SHS exposure rates during pregnancy in South Africa 
 
Pregnant women’s tobacco use and SHS exposure are current or emerging problems, 
adding to prevention of improvements in maternal and child health in low- and middle-
income countries [58].  What about South Africa? A study of South Africans’ tobacco 
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use in 1998 showed that 28% of non-smokers were exposed to SHS in their homes and 
19% were exposed in their workplace [19]. A South African study by Steyn et al. 
published in 1997, tried to estimate the active and passive smoking exposure in 
pregnant woman [87].  The study was muticentric, with 394 women from across South 
Africa [Johannesburg, Cape Town, Port Elizabeth and Durban] from private and public 
antenatal clinics.  These data was collected in 1992.   The authors reported that 70% of 
pregnant women lived with at least one smoker in the house – this seems to fulfil their 
definition of exposure, as that was the exposure rate to SHS they reported.  It was not 
stated what the criteria were for being considered exposed to SHS.  While reporting 
different figures for passive smoking and exposure to SHS, the authors did not provide 
detail on how these were differentiated.  Their study found that 91% of women thought 
second hand smoke would have a negative effect on their baby [87]. 
 
From reviewing the literature on SHS exposure in pregnancy, no recent research has 
been done to determine the exposure rate to SHS of South African pregnant women, 
especially after the introduction of anti-tobacco legislation. With high rates of smoking 
among South African men of all population groups, SHS exposure among pregnant 
women is probably not an uncommon occurrence, in homes or in the workplace.  
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2.11 SHS and preventative interventions  
 
Globally, over a third of all women are estimated to be regularly exposed to SHS [88]. 
The majority of SHS exposure among reproductive-aged women in low- and middle-
income countries happens in the home, where estimates of SHS exposure range from 
17.8% in Mexico to 72.3% in Vietnam [89]. Limited data, especially from low and middle 
income countries, is available for pregnant women. Data from 42 low and middle 
income countries during 2003-2009 found that SHS exposure rates for pregnant women 
ranged from 9.3% in the Dominican Republic to 82.9% in Timor-Leste [90]. Risk factors 
for exposure of pregnant women to smokers in the home included smokers that were 
living in the household and low level of knowledge of the harms of SHS [91]. 
 
It is estimated that 80% or more of pregnant women get antenatal care at least once 
during their pregnancy [90] and therefore the antenatal visits create an opportunity to 
screen and counsel pregnant women about SHS. In a systematic review by Tong et al. 
on clinical interventions to reduce secondhand smoke exposure among pregnant 
women, 4670 papers from 1990-2013 were reviewed, of which five studies met the 
inclusion criteria [92]. Clinical interventions included psychosocial and pharmaceutical 
interventions delivered by either the midwife or obstetrician.  One intervention focuses 
on the partners at home, promoting them to give up smoking through counselling and 
nicotine patches with follow up phone calls with more counselling.  Another intervention 
is through counselling assisted with video and information booklets, which are 
repetitively shown and reinforced at the antenatal clinic.  The systematic review 
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concluded that interventions delivered in antenatal care appear to reduce SHS 
exposure but there were study weaknesses, such as only self-reporting SHS exposure 
rate reduction with no biochemical confirmation that limited firm conclusions. 
 
The WHO also recommends strong tobacco control policies in public areas and the 
workplace. These are outlined by WHO Framework Convention on Tobacco Control 
[FCTC] [93] Public smoking bans have resulted in more homes being smoke free [94] 
and have effectively reduced  SHS exposure among pregnant women. [95, 96].  
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3. PROBLEM STATEMENT 
 
South Africa, being one of the first countries to put into place strict laws, which limited 
SHS exposure in public places, should be benefiting from less of a burden of disease 
from smoking and SHS.  
 
However, what about pregnant women in their homes and in the workplace? If there are 
high exposure rates, the women and unborn babies involved are at a significant risk for 
the negative health effects of SHS exposure. It is therefore important to obtain local 
data on SHS exposure rates in pregnancy, to inform further tobacco control measures 
with regard to home and workplace exposure by non-smokers. The pregnant population 
of Soweto, which is served by Chris Hani Baragwanath Maternity Hospital as its 
pregnancy referral centre, seemed an ideal starting point to explore the extent of SHS 
exposure in South African pregnant women, to find out how pregnant women regard 
and deal with smoking in their immediate environment.  
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4. OBJECTIVES OF THE STUDY 
 
1. To determine Soweto pregnant women’s exposure rate to SHS. 
2. To describe the demographic characteristics of pregnant women exposed to SHS. 
3. To describe, Soweto pregnant women’s knowledge, attitudes and practices 
regarding SHS exposure. 
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5. METHODS 
 
5.1 Study design 
 
This was a hospital-based, prospective, cross sectional study. 
 
5.2 Study Setting 
 
The study was carried out at Chris Hani Baragwanath Academic Hospital. This is one of 
the hospitals affiliated with the University of Witwatersrand and is situated in Soweto, 
South Africa.  This hospital has a large number of deliveries (in excess of 23 000 per 
annum) and  as a referral centre it delivers women with high-risk pregnancies, and also 
low-risk pregnancies transferred from Soweto clinics because of problems arising during 
antenatal care or in labour. About 10 000 low-risk births are conducted in seven clinics 
in Soweto, Orange Farm and Lenasia. In accordance with national guidelines on 
antenatal care, smoking in pregnancy is included in a check-list on the antenatal card, 
but SHS exposure is not recorded routinely on any document. 
 
5.3 Study population 
 
The study population was women aged 18 years and above who were delivered by 
primary caesarean section (no previous caesarean section) at Chris Hani Baragwanath 
Academic Hospital, as representing pregnant women from Soweto. There were two 
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reasons for choosing women who had primary caesarean sections: 1) they were 
hospitalized for more than 48 hours after delivery and therefore provided the opportunity 
for interviews; and 2) women with primary caesarean sections are likely to reflect the 
overall population of pregnant women throughout Soweto.   
 
The choice of women with primary caesarean section as the sample supposes that the 
risk of primary caesarean section is not related to SHS exposure. Choosing women 
after vaginal birth would have sampled mostly high-risk pregnancies having vaginal 
births in the referral unit at Chris Hani Baragwanath.  High-risk pregnant women may 
modify their exposure to SHS. If the participants had had a previous caesarean section 
they would have been referred as high-risk for part of their antenatal care and therefore 
may have had received additional antenatal education including advice regarding 
smoking. This may have made them more careful in the pregnancy, in terms of self-
education, and healthy practices, including avoidance of SHS. Sampling women with 
primary caesarean sections probably resulted in less selection bias than sampling 
women with hospital vaginal births. Salmasi et al. found from their meta analyses, there 
was no significant difference between pregnant women exposed to SHS and those who 
had a caesarean section (OR 1.10; 95% CI 0.88–1.39, four studies) [80].  Therefore, the 
data collected from the post-caesarean participants should not be viewed as a limitation 
of the study and be deemed an acceptable population sample to determine SHS smoke 
exposure rates.  
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Given the referral system in Soweto, it is impossible to avoid selection bias in choosing 
participants for community-based research from users of Chris Hani Baragwanath 
Academic Hospital for community-based research. 
 
5.4 Inclusion criteria 
 
Women over 18 years of age, who had a primary caesarean section. 
 
5.5 Exclusion criteria 
 
Participants would have previously had a caesarean section. All high risk pregnancies 
resulting from maternal or fetal causes were excluded. Examples of such exclusions 
were maternal medical conditions such as hypertension, diabetes, epilepsy, asthma or 
any other chronic medical conditions.  Fetal intrauterine growth restriction diagnosed 
antenatally was also an exclusion criterion. 
 
5.6 Sampling 
 
Sampling was done in the postnatal caesarean section ward, which consists of 10 
cubicles, each with six beds. Women were selected from the cubicles using bed 
numbers, with the occupants of individual beds selected using a random number list. On 
days that the researcher was available to collect data, she started at the selected bed 
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and sampled in ascending number order from that bed until sufficient, eligible women 
had been selected and agreed to participate, as time permitted.   
 
5.7 Sample size 
 
The researcher interviewed 100 individuals who met the criteria of the study population. 
This sample size gives 95% confidence intervals at most within ±10% of the observed 
sample percentage. The study was not powered to test hypotheses on factors 
associated with SHS exposure.  
 
5.8 Control group 
 
A control group was not applicable to this study. 
 
5.9 Data collection 
 
A prospective questionnaire using a face-to-face interview was conducted on the 
women who fulfilled the criteria (Appendix 1). A pilot study on 10 women was carried out 
to test the questionnaire.  The researcher personally interviewed each participant. Three 
women were unable to answer the questions due to language and communication 
difficulties and declined the interview. 
 
Questions included the pregnant woman’s demographic data, use of tobacco products 
and exposure to SHS in the household and at work.  Where possible, questions were 
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used from pre-existing validated survey tools: Global Tobacco Surveillance System, 
Tobacco Questions for Surveys, A subset of Key Questions from the Global Adult 
Tobacco Survey [61], 2000 US National Health Interview Survey [97] and the Smoke-
Free Families Screening Form [98]. Questions were also included from the Centers for 
Disease Control’s the health consequences of involuntary exposure to tobacco smoke: 
a report of the Surgeon General, Atlanta, GA: 2006 [40].  Some of the questions were 
adapted from the study by Bloch et al [58] to assess pregnant women’s use of tobacco 
and SHS exposure and to allow for direct comparison to the nine developing nations’ 
pregnant women’s SHS exposure rate. The two most important questions asked were 
tobacco use status and SHS exposure. 
 
5.10 Tobacco use status 
 
Participants were asked, “have you ever tried cigarette smoking, even one or two 
puffs?”  If the answer was “yes”, the participant was considered to have experimented 
with cigarettes. Following on from experimentation, questions were asked to determine 
if the participant was a regular smoker or had ever been a regular smoker. If she 
answered “yes” to smoking every day or to have smoked more than 100 cigarettes in 
her lifetime, the participant was considered to have been a regular smoker. To 
determine if she was a current smoker, the participant was asked if she currently 
smoked cigarettes every day.  
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5.11 SHS exposure 
 
All participants were asked, “how often are you indoors and around people who are 
smoking cigarettes or other types of tobacco products?”. Response options included 
always, frequently, sometimes, rarely or never. Those that responded with either always 
or frequently were considered to be exposed to SHS using the self-reporting method.  
 
5.12 Data analysis 
 
The data were entered onto a Microsoft Excel spreadsheet (Appendix 2), and then 
exported for analysis in Stata 11 software (Statacorp, College Station, Texas, USA). 
With the assistance of a statistician within the department, descriptive statistics were 
performed using frequencies with percentages and 95% confidence intervals, means 
with standard deviations, and medians with ranges where appropriate. 
 
Comparison of characteristics between groups employed the following techniques. For 
categorical data, the chi-squared test or Fisher’s exact test was used, whichever was 
appropriate. For continuous (numerical) data, Student’s t-test or Wilcoxon’s ranksum 
test was used, whichever was appropriate. Statistical significance was accepted at 
P<0.05. 
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5.13 Ethics 
 
All participants were counselled about the reason for the study. Informed consent was 
obtained following the patient agreeing to the interview. Each participant was assured 
that all data collected would remain anonymous on the data sheets (Appendix 3).     
Permission to conduct the study was sought from the University of the Witwatersrand’s 
Human Research and Ethics Committee (approval number M150503, Appendix 4) 
The designated representative of the Chief Executive Officer at Chris Hani Baragwanath 
Academic Hospital was approached for permission to conduct the study. Permission 
was granted (Appendix 5). 
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6. RESULTS 
 
6.1 Demographic and obstetric data  
 
These are summarized in Table 6.1. One hundred women participated in the study.  
Because the denominator is 100, percentages for the whole group of participants are 
not given. Their mean age was 28.0±6.2 years. The youngest participant was 18 years 
old and the oldest was 43 years old. Eighteen women were aged 35 or above.  The 
majority of the participants had a formal education in achieving their matriculation but 
33% went to school but did not matriculate. One participant reported to have never 
attended school and another four stated that they were unable to read and write in their 
home language or English.  A large proportion (68%) of participants had their caesarean 
sections for fetal distress, with another 20 having prolonged labour.  Seventy-four 
women were in stable relationships with their partners, although only nine were married. 
The median number of people living in the participants’ houses was 5.   
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Table 6.1. Demographic and obstetric data of women interviewed for SHS 
exposure; n or mean±standard deviation, or median (interquartile range) (n=100). 
 
Age (years) 
 
28.0±6.2 
Parity: 
                   1 
                   2 
                   3 
                   e 4 
 
 
34 
34 
24 
8 
Education (n=99): 
                   Did not matriculate 
                   Matriculation   
                   Tertiary education   
   
 
33 
66 
12 
Indication for caesarean section: 
                   Fetal distress 
                   Poor labour progress 
                   Breech presentation 
                   Other  
 
 
68 
20 
6 
6 
Current relationship: 
                   Single 
                   Stable relationship with partner 
                   Married  
 
 
26 
65 
9 
Number of persons living in the house 
 
5 (4-7) 
Number of children living in the house 
 
2 (1-3) 
 
 
6.2 History of personal tobacco use    
 
Just under one third (n=32) of the participants had ever tried to smoke. Of these 32 
women, four were current smokers. Sixteen women had tried other (smokeless) forms 
of tobacco, mostly snuff. Two women reported ever smoking cannabis (Table 6.2)  
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Table 6.2 Personal tobacco use histories of postnatal participants (n=100) 
 
Every tried to smoke 
 
32 
Ever smoked daily 
 
15 
Have smoked e100 cigarettes in lifetime 
 
13 
Current smoker 
 
4 
Ever used non-cigarette forms of tobacco 
 
16 
Current users of non-cigarette forms of tobacco 
 
2 
 
 
 
6.3 Risk of SHS exposure in the home  
 
Seventy three women did not permit smoking in their homes, and 50 of these reported 
that there was never anyone who smoked in their home. Forty-three participants lived 
with smoker, 27 of them (63%) with one smoker, and 12 (28%) with two smokers.  
 
The median of number of cigarettes smoked in the house daily was 5. Almost half 
(n=49) of the participants stated they were sometimes around friends or family who 
smoked indoors. Eight reported being indoors around smoking individuals “frequently”, 
and 13 stated that they were “always” exposed to smoking individuals. Twenty 
participants reported always having someone smoking inside the home, but only 13 
stated they were exposed, as the other seven removed themselves from the parts of the 
house where the smoking occurred to avoid SHS. Therefore, from the definition of SHS 
given earlier, 21% of the women were exposed to SHS (95% confidence interval 13.5 to 
30.3). 
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Table 6.3 Risk of SHS exposure in the home; n or median (interquartile range) 
(n=100). 
 
Smoking not allowed in the home 
 
73 
Never have anyone smoking in the home  
 
50 
Always have someone smoking inside the home 
 
20 
Live with a regular smoker 
 
43 
Number of smokers living in the house 
 
0 (0-1) 
Number of cigarettes smoked by smokers at home per day, 
estimated by participant 
 
5 (2-10) 
“Always” or “frequently” indoors and around people who smoke  
 
21 
“Sometimes” indoors and around people who smoke 
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6.4 SHS exposure at the workplace 
 
 
Only 33% of the participants were found to be employed and the majority (n=30; 91%) 
of those employed worked indoors. Most of the places of work were found to have 
designated smoking areas and 27 (82%) reported that smoking was prohibited indoors. 
Six of the employed women (18%; 95% confidence interval 7.0 to 35.5) reported 
smoking occurred “frequently” or “always” around them indoors at their workplace.   
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Table 6.4 SHS exposure at the workplace; n (%) or median (interquartile range) 
(n=33). 
 
Currently employed  
 
33 
Did anyone smoke indoors at work during this pregnancy 
 
6 (18%) 
Always or frequently indoors and around people who smoke at 
work 
 
6 (18%) 
Number of cigarettes smoked by smokers at work per day, 
estimated by participant 
 
6 (5-15) 
 
 
 
6.5 Knowledge and attitude towards smoking and SHS 
 
 
Ninety two of the participants, even though some were smokers themselves, said they 
did not think it was acceptable for women to smoke and 91 thought that SHS would 
have an effect on their baby.  Seventy three had banned smoking in their house.  Ten 
participants where smoking was not banned mentioned thematically in different ways 
that they felt as women they were not entitled to institute bans as they were not the 
owners of the homes.   
 
 
Table 6.5 Knowledge, attitudes and practices regarding smoking and SHS 
exposure (n=100) 
 
It is unacceptable for woman to smoke  
 
92 
SHS has a negative effect of your baby’s health while pregnant 
 
91 
Participant has banned smoking in the house 
 
73 
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6.6 Comparison of pregnant woman exposed to those non-exposed to SHS  
 
 
The only parameter which showed statistical significance between the exposed and the 
non-exposed group was the number of regular smokers that lived in the house, all the 
other parameters examined showed no difference.  
 
 
Table 6.6 Comparison of women exposed to SHS in pregnancy with those not 
exposed, with respect to socioeconomic and domestic factors; n(%), 
median(interquartile range, mean±standard deviation. 
 
 Exposed to 
SHS (n=21) 
Not exposed 
to SHS 
(n=79) 
P value 
Age in years 
 
28.0±6.9 27.9±6.1 0.94 
Parity 
 
2 (1-3) 2 (1-3) 0.86 
Matriculation achieved 
 
11 (52%) 55 (71%) 0.13 
Number of people living in the home 
 
6 (3-9) 5 (4-6) 0.48 
Number of children living in the home 
 
2 (1-3) 2 (1-3) 0.90 
Number of regular smokers living in the home 
 
1 (1-2) 0 (0-1) <0.01 
Employed 
 
4 (19%) 29 (37%) 0.19 
 
 
6.7 Comparison of women who banned smoking in their homes to those who did 
not.  
 
 
Higher education status was associated with a greater likelihood of the woman banning 
smoking (P<0.01).  If the participants did not live with a regular smoker, they were more 
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likely to ban smoking in the house as this parameter was also found to be statistical 
significant.   
 
 
Table 6.7 Comparison of women who banned smoking in their homes with those 
who have not, with respect to socioeconomic and domestic factors; n(%), 
median(interquartile range), mean±standard deviation. 
 
 Smoking not 
banned (n=27) 
Banned 
smoking 
(n=73) 
P value 
Age in years 
 
28.6±6.1 27.7±6.3 0.51 
Parity 
 
2 (1-3) 2 (1-3) 0.43 
Matriculation achieved 
 
12 (44%) 54 (75%) <0.01 
Number of people living in the home 
 
6 (4-11) 5 (4-6) 0.08 
Number of children living in the home 
 
2 (1-4) 2 (1-2) 0.02 
Number of regular smokers living in the 
home 
 
1 (1-2) 0 (0-1) <0.01 
Employed 
 
5 (19%) 28 (38%) 0.09 
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7. DISCUSSION 
 
It appears that no recent research has been done regarding SHS exposure rates in any 
South African pregnant population. The study provides a look at South African women 
from an urban environment, and has shown that SHS exposure is common at home and 
at work. Exposure levels in the workplace are of some concern, given the South African 
tobacco regulations in place to protect non-smokers. Most pregnant women are aware 
of the potentially harmful effects of SHS, and the knowledge of potential harms appears 
to have translated into banning of smoking in homes by a majority of the women 
interviewed.  
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7.1 Demographic and Obstetric data 
 
The participants have a mean age of 28 years. This is aligned with the other nine low-
to-middle income countries reviewed by Bloch et al. and specifically the African 
countries, Zambia and the DRC, where the mean ages were 25 and 27 respectively, but 
a few years older than those participants in the South African study by Steyn et al. 
where the mean age was 23. [57,58,87]. The importance with regards to comparison of 
age in relation to the other studies is to ensure that we are comparing a similar aged 
population as a younger population may have a higher risk perception due to social 
awareness of smoking than that of  older populations, but also one needs to consider 
that smoking initiation generally occurs at a younger age resulting in more younger 
people smoking. In our study there was no statistical significance when comparing age 
and if smoking was banned in the house or for woman who were exposed to SHS which 
was unexpected.  We expected that the older the participant, the more likely she would 
be inclined to ban smoking, feeling less peer pressure and having a measure of 
seniority in the home.   
 
In our study 43% of the participants lived with a regular smoker, and 16% of these 
participants lived with more than one regular smoker in the house.  Living with a regular 
smoker was not as frequent in other African countries such as Zambia and the DRC 
[58].  Previous research carried out in South Africa by Steyn et al. in 1992 [87] showed 
that 50% of women lived with one or two smokers and 19.6% of their participants lived 
with more than two smoker.  The fact that South Africa introduced their anti-smoking 
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laws after this research may account for this difference, as the authors of the 5th 
Tobacco Atlas found that smoking prevalence was reduced by 5% within three years in 
countries with a ban on direct and indirect marketing of cigarettes [15].   
 
7.2 History of personal tobacco use    
 
Steyn et al reported that African women used smokeless tobacco such as snuff more 
frequently than other population groups but our research showed that participants had 
tried cigarette smoking more than smokeless tobacco substances. Our cigarette 
experimentation rate is low, but not as low as in Zambia and the DRC [58].  
 
15% of the participants indicated that they had been regular smokers but only 4% were 
current smokers. This is substantially lower than what was found in 1992 by Steyn et al. 
as they reported that 21% of pregnant women smoked.  On further analysis of the paper 
by Steyn et al, the results were collected by race group. Only 3.6% of black women 
were smokers and considering our research was carried out in Soweto where it was not 
stated, but in fact all participants were black, this suggests no change in the current 
smoker figure for black pregnant women.   In Zambia and the DRC less than 1% of the 
women had ever been regular smokers [57].  
 
South African data from this study shows some similarities with African countries and 
also with other middle-income countries.  Each country has its own unique 
circumstances, and data from one country cannot be readily extrapolated to another, 
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especially regarding a phenomenon such as smoking in pregnancy, which has multiple 
social, cultural and economic determinants. This further justifies the need for updated 
tobacco use research in the country, including the pregnant population with attention to 
exposure rates and attitudes to SHS. 
 
7.3 Risk of SHS exposure in the home  
 
Smoking was permitted in 27% of homes in our study, which is substantially less than 
the 76% of homes in countries such as the Dominican Republic (76%), Pakistan (92%), 
and India (55%) [58].  Other African countries displayed lower rates than those in South 
Africa, as Zambia had a 20% and the DRC a 17% rate of smoking permitted in the 
house [57].    From the data we know there are fewer smokers in Africa than compared 
to the rest of the world and those countries mentioned above, which makes the banning 
of smoking much more achievable when the prevalence of smoking is so much less in 
the population.  The relatively high rate of banning smoking in the home is however not 
necessarily from the African population adopting sophisticated strategies to avoid SHS, 
but rather that there are fewer smokers and therefore instituting a ban is easier. 
Increases in smoking prevalence in adults as a whole are likely to increase 
permissibility of smoking in homes and exposure rates to SHS. 
  
From previous research done in South Africa, 50% of women were considered passive 
smokers, yet exposure was defined if you lived with a smoker, which is not the same 
definition we used to determine SHS exposure in our study.  It is difficult to compare 
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data when the definition of SHS exposure is not the same as this made lead to incorrect 
comparisons and conclusions.   This was also considered a research limitation as 
discussed by Tong et al [92]. Clear international guidelines of measuring SHS exposure 
are needed to provide robust comparable estimates to establish if SHS exposure in 
pregnancy is indeed reducing or increasing.    
 
Of the 21 participants exposed to SHS, 38% reported that they had banned smoking in 
their homes. Steyn et al. found in 1992 that 50% of women were classified as passive 
smokers but looking at the specific race breakdown, 62% of black women reported to be 
passive smokers. It appears, if the Soweto data reflect national trends, that there has 
been a substantial reduction in the overall SHS exposure, which could be attributed to 
the anti-tobacco laws.  In spite of this reduction, a 21% current exposure rate in our 
pregnant population remains unacceptable, and important efforts need to be made to 
ensure a significant reduction, such interventions are discussed below.      
 
7.4 SHS exposure at the workplace 
 
Eighteen percent of the employed women could be classified as being exposed to SHS 
at work. With wide confidence intervals because of the small number of employed 
women, this estimate lacks precision (confidence interval of 95%). Most of the 
employed participants reported that smoking never occurred indoors as there were strict 
policies in place regarding smoking in the workplace proving that the majority of formal 
workplaces have enforced the rules laid down by the Tobacco Control Act of 1993.  But 
the approximately 18% who were exposed suggest a failure in enforcement of health-
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promoting legislation. Unfortunately more detail should have been analysed with 
regards to the type of employment (formal vs informal) as to where the most amount of 
exposure was occurring.     
 
7.5 Knowledge and attitude regarding smoking and SHS, and potential 
interventions to reduce SHS exposure 
 
Tong et al. showed that interventions can be used to reduce SHS exposure as well as 
increase the rate of giving up smoking in the partner. For the pregnant woman, we 
believe that the simple intervention of education in the ANC by both the obstetrician and 
the midwife could be introduced in South Africa.  Besides face-to-face discussion, 
information booklets for women to take home and share the information with their 
partners should be available for all pregnant women.  South Africa should capitalise on 
the long waiting periods in our clinics.  This is an ideal opportunity to educate and role-
play to a captive audience, ways in which to approach the topic of banning smoking in 
the home once they get home.  Research on the most appropriate local educational 
tools on pregnancy smoking and SHS exposure is however lacking. 
 
7.6 Comparison of pregnant woman exposed to those non-exposed to SHS 
 
The demographics of the participants who were found to be exposed to SHS were 
similar to the demographics of the non-exposed group. We could not identify a specific 
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risk group for SHS exposure, other than living with regular smokers, for which there 
was, as expected, a higher likelihood of SHS exposure.     
 
7.7 Comparison of woman who banned smoking in their homes to those who did 
not 
 
The comparison between number of regular smokers in the house and whether smoking 
was banned was statistically significant in terms of a positive association with fewer 
regular smokers in the home. It appears from our results that women were unable to, or 
would not, ban smoking if there were regular smokers in their homes.  There was a 
statistical significance when comparing level of education and banning smoking in the 
house. The higher the education level, the more likely one is to ban smoking in the 
home.  Chomba et al. found that literate woman were significantly less likely to live with 
other tobacco users, to live in a home where smoking was allowed and to report that 
they or their children were exposed to SHS [57].  The most common reason for not 
banning smoking in homes that participants lived in was that they felt since they were 
not the owner of the house they did not have the right to ban smoking, especially if the 
owner of the house was a smoker.  Most women felt as if they wishes or requests were 
ignored as often they reported to have thought about banning smoking and some had 
even requested it, but were simply ignored and therefore the ban was not maintained.  
Gender equality and the rights of the African women in the home leads to an important 
debate, beyond the scope of this study, but which can be explored in additional studies.     
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The premise that educating a woman in turn educates a community should be 
considered, in order to empower women to be able to make health-promoting changes 
within the household, ultimately benefiting the whole family.  Banning of smoking 
indoors should become an accepted norm and this can only be achieved by having buy-
in from government, policymakers, men and women. 
 
7.8 Limitations 
 
One of the limitations of the study was a lack of detail in the questionnaire.  Participants 
were asked if they knew if SHS harmed their baby while pregnant, but the knowledge of 
what damage or what affect the SHS has on them and on their baby was not 
questioned.  The sample size of 100 was perhaps adequate for a pilot study to explore 
SHS exposure rates, but subgroups were too small to analyse further. 
Only one particular race group from one area was investigated within the study and as 
other studies have showed there are significant differences of tobacco consumption 
within different racial groups within South Africa. Findings and estimates cannot be 
extrapolated beyond urban African women who use public health services.  The method 
used for self-reporting of SHS exposure was adequate as most of the questions used 
were multiple choice question, but we did not verify the information with biochemical 
cotinine levels.  It was also not determined if there was any difference in the exposure to 
SHS throughout the different pregnancy trimesters.  The study had clear but limited 
objectives. This, combined with the small sample allows only a preliminary 
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understanding of the magnitude of the potential health problem that SHS presents in 
South Africa.  
 
8. CONCLUSION 
 
The use of tobacco by pregnant women and the exposure of pregnant woman and their 
children to SHS flies in the face of many improvements made in maternal and child 
health.  This exploratory study suggests that, at least in South African urban areas, 
there is significant exposure by pregnant women to SHS, probably higher than that of 
other African countries. This threatens to add to the burden of tobacco-related illness 
among some of the most vulnerable groups of people.   
 
Research is needed on feasible methods of communicating SHS risks to the general 
population and to pregnant women. Such methods may be incorporated into the 
antenatal care programme to take advantage of the opportunity where the women has 
actively sought out healthcare and may be more receptive and motivated to make 
health changes. Lectures, counselling, leaflets and role plays may be appropriate and 
prove to be effective.  Further research should focus on high SHS exposure rates in 
spite of the firm tobacco controls within South Africa.  Results could assist policymakers 
with regard to where stricter controls should be put into place.  As recommended by the 
WHO, comprehensive smoke-free home legislation should be considered by 
policymakers in conjunction with the above self-motivation techniques through 
education to reduce SHS exposure rate. Proposals to reduce smoking overall, such as 
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raising excise taxes further and banning branding of packaging, and criminal 
prosecution of illegal cigarette traffickers, should be enacted to reduce cigarette sales 
further.   
 
Many things, as discussed above, can be put into place in order to reduce SHS 
exposure.  The most reassuring premise is that simple inexpensive tried and tested 
methods at the antenatal clinic, could put the proverbial wheels in motion towards a 
zero rate of SHS exposure for pregnant women in South Africa.    
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APPENDIX 1 
Interview questionnaire 
Study No:  Age in years:  
Parity/Gravidity:  Date:  
1. Highest level of education 
No school  Junior school High School       
(Grade 12) 
Tertiary education 
2. Are you able to read and write in your home language or English?  
Yes   No  
3. Indication for caesarean section: 
Fetal distress  Grand Multiparity  
Prolonged labour  Unknown  
Cephalopelvic disproportion   
4. Do you work for pay? 
Yes   No  
5. What is your relationship status? 
Single Married Divorced In a relationship 
6. Do you live in Soweto? 
Yes   No  
7. How many people are living in your home? 
 
8. How many of the people in your home are children? 
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9. How old are the children in the house? 
Under 5 5-17 18 nd over 
10. Have you ever tried cigarette smoking, even one or two puffs? 
Yes   No  
10. Have you ever smoked daily? 
Yes  No  
11. Have you smoked more than 100 cigarettes in your lifetime? 
Yes  No  
12. Do you currently smoke? 
Yes  No  
13. Have you ever tried any other forms of tobacco, besides cigarettes? 
Yes  No  
14. If, yes – which other types? 
 
15. Have you used this product/s daily? 
Yes  No  
16. Have you used this product more than 100 times in your lifetime? 
Yes  No  
17. Do you currently use other forms of tobacco? 
Yes  No  
18. Is smoking allowed in your house? 
Yes  No  
78 
19. How often does anyone smoke inside your home? 
Always  Frequently  
Sometimes  Rarely  
Never    
20. How many regular smokers live in your house? 
 
21. How many cigarettes are smoked in your house per day if you live with a regular 
smoker? 
 
22. How often are you indoors and around people who are smoking cigarettes or other types 
of tobacco products? 
Always  Frequently  
Sometimes   Rarely  
Never     
23. Are you employed outside the home? 
Yes  No  
24. Do you currently work? 
Indoor   Outdoor  
Both  Unemployed   
25. During the pregnancy, did anyone smoke in indoor areas where you work? 
Yes  No  
Unknown    
26. How often does anyone smoke inside your place of work? 
79 
Always  Frequently  
Sometimes   Rarely  
Never     
27. How many cigarettes are smoked in your place of work per day by a regular smoker? 
 
28. Do you think it is acceptable for women in your community to smoke cigarettes, or not? 
Yes  No  
29. Do you know if secondhand smoke could have had any effect on your baby? 
Yes  No  
30. Have you banned smoking in your house? 
Yes  No  
31. If no, why not? 
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Question no Question Yes No Unknown Other Always Frequently Sometimes Rarely Never
No 
school
Junior 
school
High 
school Tertiary
Fetal 
distress
Prolonged 
labour CPD
Grand 
Multiparity
under 
5 5y - 17y
18 or 
older
Age
Parity
Gravitiy
1 Highest level of education
2 Are you able to read and write in your home language or English
3 Indication for caesarean section
4 Do you work for pay?
5 Are you married or in a relationship?
6 Do you live in Soweto?
7 How many people are living in your home?
8 How many of the people in your home are children?
9 How old are the children in the house?
10 Have you ever tried cigarette smoking , even one or two puffs?
11 Have you ever smoked daily?
12 Have you smoked more than 100 cigarettes in your lifetime?
13 Do you currently smoke?
14 Have you ever tried any other forms of tobacco, besides cigs 
15 If, yes – which other types?
16 Have you used this product/s daily?
17 Have you used this product more than 100 times in your lifetime?
18 Do you currently use other forms of tobacco?
19 Is smoking allowed in your house?
20 How often does anyone smoke inside your home?
21 How many regular smokers live in your house?
22
How many cigarettes are smoked in your house per day if you live with 
a regular smoker?
23
How often are you indoors and around people who are smoking 
cigarettes or other types of tobacco products?
24 Are you employed outside the home?
25 Do you currently work?
26
During the pregnancy, did anyone smoke in indoor areas where you 
work?
27 How often does anyone smoke inside your place of work?
28
How many cigarettes are smoked in your place of work  per day by a 
regular smoker?
29
Do you think it is acceptable for women in your community to smoke 
cigarettes, or not?
30
Do you know if secondhand smoke could have had any effect on your 
baby?
31
If you knew that there were harmful effects on your baby would you 
have avoided second hand smoking?
32 Would you have banned smoking in your house?
Data Collection Sheet 
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APPENDIX 3 
Patient information and consent form 
GOOD DAY. 
My name is Dr Joanne Pottow. I am a doctor training to be a specialist working at Chris 
Hani Baragwanath Hospital. I am doing a research project to achieve a master’s degree 
(MMed) with Wits University as part of my training. I am inviting you to participate in this 
project.  This form has information to help you decide if you want to take part. Read it 
carefully and feel free to ask me or any staff member for assistance.  
What is the project about? 
We are trying to find out how many women during their pregnancy are around people 
who smoke either at home or at work.  We would also like to ask you how you feel 
about smoking during pregnancy and how you feel about being around people who 
smoke while you are pregnant.  
Why have I been chosen to participate?  
You have been chosen because you have had your first caesarean section and are 
going to be staying with us for two days.  As you know, the antenatal clinic and the other 
wards are very busy and don’t give us the chance to sit down with you and ask you 
these questions. That is why you have been chosen to participate. 
I would like to get some information from your records  
I will be asking you a few questions, which will take 10 minutes, with regards to your 
pregnancy and if you lived with people who smoked.  I will also take information from 
your card.   
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How do I gain by participating in this project? 
You do not gain directly. What I am doing will not affect the way you are treated. This is 
a research project where we want to find out how to improve care for pregnant woman 
in the future. Also, you will not receive any reward for agreeing to participate in this 
project. 
Will there be any harm to my baby or me if I participate? 
There will not be any harm to you or your baby in any way.  The information obtained 
from asking you the questions will have no effect on any further treatment you will 
receive from the hospital.  Whether or not you take part in this research project is 
completely your choice. 
Could the information obtained in my file end up in the wrong hands?  
No. Everything I find out about you is strictly confidential. All the information will go on to 
my special form that will not have your name or hospital number on. The form contains 
only a study number and I will be the only person who knows that the study number is 
yours.  
What will happen if I do not want to participate?  
You are free to refuse to take part in the project. It will not affect the way you are treated 
by nurses and doctors here. Even if you sign the consent form to participate, and you 
change your mind later, you may withdraw from the project.  
That is your decision and I respect that. 
Who can I speak to if I have a question regarding the research? 
If you have any questions about the research, you may ask the doctor or nurse who is 
attending to you in the hospital, or you can speak to me directly on 0832349107, even 
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after you have left the hospital. This research has also been approved by the University 
of the Witwatersrand’s Human Research and Ethics Committee. If you have any queries 
about whether this study is safe or allowed to be done, you may call the committee’s 
secretary, Ms Anisa Keshav, at 0117171234 during working hours. 
Thank you 
 
Consent  
I agree to participate in this project. Dr Pottow will take information from my card, ask 
me a series of questions which will not take more than 15 minutes.  She will write down 
the answers on her collection papers.  
The forms she uses in this project will not include my name or hospital number. I 
understand that I am not entitled to any gain for me taking part in the project. I also 
understand that I may withdraw my consent for participation at any time, even after I 
have signed this form.  
 
• Participant  
 
• Researcher 
 
• Time  
 
• Date  
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ETHICS APPROVAL  
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CEO PERMISSION LETTER 
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TURNITIN REPORT 
 
